Skip to main content
Clinical Trials/NCT03817385
NCT03817385UnknownNot Applicable

Effect of Repetitive Transcranial Magnetic Stimulation (rTMS) and Robotic Gait Training on Lower-extremity Function and Gait in Patients With Stroke

Changhua Christian Hospital1 site in 1 country105 target enrollmentStarted: February 1, 2019Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
105
Locations
1
Primary Endpoint
Change of walking speed

Study Overview

Brief Summary

Patients with stroke have demonstrated abnormal muscle tone and postural control ability which affect their ambulation, activity of daily living and confident. Nowadays, utilizing repetitive transcranial magnetic stimulation (rTMS) and robotic machines to assist walking training for stroke patients has been applied to clinic widely. While less studies have compared intervention efficacy for stroke patients between rTMS and robotic training. This study aimed to compare effect of rTMS and robotic training for lower-extremity function and gait in stroke patients.

Detailed Description

This study will include subjects occurring stroke within 3 months. All groups will receive traditional rehabilitation. The subjects will be allocated randomly in three groups which are traditional rehabilitation (Group A), robotic training (Group B), and rTMS (Group C) respectively, with 35 people per group. The group B will be intervened 5 times per week and the group C will receive 10 times rTMS intervention during 4 weeks. At post-intervention and eighth weeks after intervention, basic examination will be executed including basic information, history, Mini-mental State examination, Short -Form 36, Modified Ashworth Scale, Fugl-Meyer assessment, static and dynamic motion examination, ultrasound assessment and examination of cardiorespiratory. Two-way mixed ANOVA will be used to analyze the differences of three groups and times.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
20 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •first-time onset of stroke
  • •reaching 20 years old and having clinical CT and MRI diagnosis of stroke
  • •hemiparesis with sitting ability after onset 3 months

Exclusion Criteria

  • •Brunnstrom stage over grade V
  • •Combined other neurological diseases (epilepsy, polyneuropathy, Meniere's disease, vestibular neuritis, Parkinson's disease, dementia, spinocerebellar ataxia)
  • •lower extremity disease, included joint contracture, high muscle tone(MAS more than 3), L/E fracture, Joint replacement, long-term osteoarthritis pain
  • •unstable vital sign
  • •can't coordinate or Sign consent plan form

Arms & Interventions

repetitive TMS (Transcranial Magnetic Stimulation)

Experimental

rTMS and physical / occupational therapy

Intervention: repetitive TMS (Device)

robotic GT (Gait Training)

Experimental

robotic gait training for 20 times and physical / occupational therapy

Intervention: robotic GT (Device)

traditional rehabilitation

No Intervention

patient only received traditional rehabilitation program

Outcomes

Primary Outcomes

Change of walking speed

Time Frame: baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention

walk 6m to measure the time spent, patients can walk with foot orthosis and assistive devices

Change of postural sway displacement

Time Frame: baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention

Use computerized dynography to measure the postural sway displacement (mm)

Change of postural sway velocity

Time Frame: baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention

Use computerized dynography to measure the postural sway velocity (mm/s)

Change of postural sway area

Time Frame: baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention

computerized dynography to measure the postural sway area (mm\^2)

Change of step time

Time Frame: baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention

Use computerized dynography to measure spatial gait parameter: step time (ms)

Change of stance time

Time Frame: baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention

Use computerized dynography to measure spatial gait parameter: stance time (ms)

Change of swing time

Time Frame: baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention

Use computerized dynography to measure spatial gait parameter: swing time (ms)

Change of single support time

Time Frame: baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention

Use computerized dynography to measure spatial gait parameter: single support time (ms)

Change of step length

Time Frame: baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention

Use computerized dynography to measure spatial gait parameter: step distance (mm)

Change of stance length

Time Frame: baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention

Use computerized dynography to measure spatial gait parameter: stance distance (mm)

Change of amplitude of Muscle activity

Time Frame: baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention

use electromyography to measure the muscles activity in microvolts (uv) included quadriceps, hamstrings, tibialis anterior, gastrocnemius during subject walking in self selected speed in 6 meters.

Change of Functional Independence Measure (FIM)

Time Frame: baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention

FIM™ is comprised of 18 items, grouped into 2 subscales - motor and cognition. The motor subscale includes: Eating Grooming Bathing Dressing, upper body Dressing, lower body Toileting Bladder management Bowel management Transfers - bed/chair/wheelchair Transfers - toilet Transfers - bath/shower Walk/wheelchair Stairs The cognition subscale includes: Comprehension Expression Social interaction Problem solving Memory Each item is scored on a 7 point ordinal scale, ranging from a score of 1 to a score of 7. The higher the score, the more independent the patient is in performing the task associated with that item. The total score for the FIM motor subscale will be a value between 13 and 91. The total score for the FIM cognition subscale will be a value between 5 and 35. The total score for the FIM instrument will be a value between 18 and 126.

Change of international Quality of Life Assessment Short Form -36 (SF-36)

Time Frame: baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention

including 8 health concepts: (1) physical functioning, (2) role limitations because of physical health problems; (3) bodily pain, (4) social functioning, (5) general mental health (psychological distress and psychological wellbeing), (6) role limitations because of emotional problems, (7) vitality (energy/fatigue), (8) general health perceptions. Scoring: answers to each question are scored which are then summed and transformed to a 0 - 100 scale.

Change of double support time

Time Frame: baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention

Use computerized dynography to measure spatial gait parameter: double support time (ms)

Secondary Outcomes

  • Change of concentration of Serum albumin(baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention)
  • Change of concentration of Hemoglobin (Hb)(baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention)
  • Change of concentration of Glucose(baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention)
  • Change of concentration of Cholesterol(baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention)
  • Change of concentration of Triglyceride(baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention)
  • Change of Berg balance test (BBS)(baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention)
  • Change of Fugl-Meyer Assessment (FMA)(baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention)
  • Change of Modified Ashworth scale (MAS)(baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention)
  • Change of Muscle tone(baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention)
  • Change of Body Mass Index (BMI)(baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention)
  • Change of Mini-mental state examination (MMSE)(baseline: before intervention, 1st examination: finish the intervention(repetitiveTMS:10 times treatments(2weeks);robotic GT:20 times treatments (4weeks)), 2nd examination: 7 weeks after intervention)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Ta-Sen Wei,MD

Director, Physical Medical and Rehabilitation, Principal Investigator, Clinical Professor

Changhua Christian Hospital

Study Sites (1)

Loading locations...

Similar Trials